Skip to main content
Log in

Clinical medication review in elderly with polypharmacy saves cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Drug use Reconsidered in the Elderly using goal Attainment scales during Medication Review

Reference

  • Verdoorn S, et al. Cost-utility and cost-effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care; economic evaluation of the DREAMeR study. British Journal of Clinical Pharmacology : 10 Jun 2020. Available from: URL: http://doi.org/10.1111/bcp.14421

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clinical medication review in elderly with polypharmacy saves cost. PharmacoEcon Outcomes News 856, 8 (2020). https://doi.org/10.1007/s40274-020-6908-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6908-0

Navigation